|
|
Clinical effect of Thymosin α1in the treatment of digestive system tumors in elderly patients |
FAN Ming-juan |
Department of Gastroenterology,the First People′s Hospital of Guangzhou City in Guangdong Province,Guangzhou 510180,China |
|
|
Abstract Objective To study the clinical effect of Thymosin α1in the treatment of digestive system tumors in elderly patients.Methods A total of 100 elderly patients with digestive system tumors from August 2016 to December 2017 in our hospital were selected as research objects and they were divided into the control group and the observation group according to the computer randomization,with 50 cases in each group.The control group was treated with conventional chemotherapy,and the observation group was treated with Thymosin α1.The immune function,Karnofsky scores before and after treatment and total effectiveness rate were compared between the two groups.Results The levels of CD3+,CD4+,CD8+,CD4+/CD8+,NK lymphocyte in the two groups after treatment were better than those before treatment,with statistically significant differences(P<0.05).The levels of CD3+,CD4+,CD8+,CD4+/CD8+,NK lymphocyte in the observation group after treatment were better than those in the control group,with statistically significant differences(P<0.05).The total effective rate of the observation group was higher than that of the control group,with statistically significant difference(P<0.05).The Karnofsky scores of the two groups after treatment were higher than those before treatment,and the differences were statistically significant(P<0.05).The Karnofsky score of the observation group after treatment was higher than that of the control group,with statistically significant difference (P<0.05).Conclusion Thymosin α1has a significant effect on treating digestive system tumors in elderly patients,which can improve immune function of patients with high safety and it is worthy of further study.
|
|
|
|
|
[1] |
周琴,左明焕,李泉旺,等.胃瘫外敷方穴位贴敷治疗消化系统肿瘤患者术后胃瘫的多中心临床研究[J].中华肿瘤杂志,2017,39(12):919-925.
|
[2] |
荀静宇,李福军,孙晨,等.miR-135a在消化系统肿瘤中的研究进展[J].胃肠病学和肝病学杂志,2017,26(7):816-818.
|
[3] |
陶灵佳,任建琳,季青,等.外泌体在消化系统肿瘤中的研究进展[J].国际消化病杂志,2017,37(3):164-167.
|
[4] |
郭海,赵晓峰,吉福志,等.周仲瑛教授消癌解毒方治疗消化系统肿瘤机制[J].吉林中医药,2016,36(7):671-673.
|
[5] |
万鸿,万里鹏,刘静,等.胸腺肽α1对高龄患者消化系统肿瘤的临床效果研究[J].胃肠病学和肝病学杂志,2013,22(11):1105-1107.
|
[6] |
刘碧原,谢鸣.中药与氟尿嘧啶联用治疗消化系统肿瘤的增效减毒作用[J].中国药师,2017,20(7):1224-1228.
|
[7] |
张明黎,王业涛,宋继中,等.内镜黏膜下挖除术治疗消化道黏膜下肿瘤 108例分析[J].中华消化杂志,2013,33(11):756-760.
|
[8] |
亓久德,郭本成.局部热疗联合最佳支持治疗改善消化系统肿瘤恶病质临床观察[J].实用肿瘤杂志,2013,28(1):53-56.
|
[9] |
钦伦秀,孙豪庭,王超群,等.外泌体在消化系统肿瘤精准诊断与治疗中的应用[J].中华消化外科杂志,2018,17(4):333-337.
|
[10] |
连娇燕,金海,国容,等.miR-17-5p与消化系统肿瘤关系的研究进展[J].山东医药,2016,56(24):101-103.
|
[11] |
龚剑.奥曲肽治疗消化系统肿瘤内出血患者的应用效果观察[J].临床合理用药杂志,2017,10(29):38-39.
|
[12] |
侯荣华.药物治疗消化系统肿瘤术后消化功能不全的临床效果[J].临床医药文献电子杂志,2017,4(36):7059.
|
[13] |
邓波儿,化怡纯,王婧,等.消化系统肿瘤骨转移的早期识别与相关治疗及药物的研究进展[J].中国医院用药评价与分析,2017,17(7):876-878.
|
[14] |
梁文全,陈凛,郗洪庆,等.紫草素在消化系统肿瘤中的抗癌机制研究进展[J].现代生物医学进展,2017,17(15):2977-2980.
|
[15] |
张世军,姜秋颖.恩度联合化疗治疗消化系统晚期癌症的临床研究进展[J].现代肿瘤医学,2017,25(13):2178-2182.
|
|
|
|